<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peripartum <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, a type of <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> of unknown origin, occurs in previously healthy women in the final month of pregnancy and up to 5 months after delivery </plain></SENT>
<SENT sid="1" pm="."><plain>Although the incidence is low-less than 0.1% of pregnancies -morbidity and mortality rates are high at 5% to 32% </plain></SENT>
<SENT sid="2" pm="."><plain>The outcome of peripartum <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is also highly variable </plain></SENT>
<SENT sid="3" pm="."><plain>For some women, the clinical and echocardiographic status improves and sometimes returns to <z:mpath ids='MPATH_458'>normal</z:mpath>, whereas for others, the disease progresses to severe <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> and even <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0011009'>acute</z:hpo> care, treatment may involve the use of intravenous <z:chebi fb="1" ids="35620">vasodilators</z:chebi>, inotropic medications, an intra-aortic balloon pump, ventricular-assist devices, and/or extracorporeal membrane oxygenation </plain></SENT>
<SENT sid="5" pm="."><plain>Survivors of peripartum <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> often recover from left ventricular dysfunction; however, they may be at risk for recurrence of <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> in subsequent pregnancies </plain></SENT>
<SENT sid="6" pm="."><plain>Women with <z:hpo ids='HP_0011010'>chronic</z:hpo> left ventricular dysfunction should be managed according to guidelines of the American College of Cardiology Foundation and the American Heart Association </plain></SENT>
</text></document>